Cleared Traditional

ORTIV (ORTIV-BL, ORTIV-WH) (K241646) - FDA 510(k) Clearance

Class II General & Plastic Surgery device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2024
Decision
147d
Days
Class 2
Risk

K241646 is an FDA 510(k) clearance for the ORTIV (ORTIV-BL, ORTIV-WH). Classified as Powered Laser Surgical Instrument within the GEX classification (a category for powered laser surgical instruments across multiple specialties), Class II - Special Controls.

Submitted by Mvitro Co., Ltd. (Seoul, KR). The FDA issued a Cleared decision on November 1, 2024 after a review of 147 days - within the typical 510(k) review window.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4810 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Mvitro Co., Ltd. devices

Submission Details

510(k) Number K241646 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 07, 2024
Decision Date November 01, 2024
Days to Decision 147 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
32d slower than avg
Panel avg: 115d · This submission: 147d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GEX Powered Laser Surgical Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4810
Definition A Laser (light Amplification By Stimulated Emission Of Radiation) Based Device Having Coherence, Collimated And Typically Monochromatic Radiation. Typically Indicated To To Cut, Destroy, Remove Or Coagulate Tissue, Generally Soft Tissue, For General Surgical Purpose In Medical Specialties Of General And Plastic Surgery, Dermatology/aesthetic, Podiatry, Otolaryngology (ent), Gynecology, Neurosurgery, Orthopedics (soft Tissue), Dental And Oral Surgery, And Dentistry. The Classification Regulation 21 Cfr 878.4810 Describes A Device That Is Carbon Dioxide Or Argon Laser Intended To Cut, Destroy, Remove Or Coagulate Tissue By The Light.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - GEX Powered Laser Surgical Instrument

All 536
Devices cleared under the same product code (GEX) and FDA review panel - the closest regulatory comparables to K241646.
Medical Thulium Fiber Laser Systems (UroFiber 60Q)
K242293 · Rhein Laser Technologies Co., Ltd. · Nov 2024
Diode laser Treatment System (K18)
K241498 · Hebei Keylaser Sci-Tech Co.,Ltd · Nov 2024
Veincare
K241930 · Wontech Co., Ltd. · Nov 2024
Rapido Medical Laser (Rapido MED, Rapido Derma, Rapido ENT, Rapido Podia)
K240543 · Medency S.R.L. · Oct 2024
Fractional CO2 Laser Therapy System (EXFU CO2)
K242183 · Weifang Mingliang Electronics Co., Ltd. · Oct 2024
FREDDO
K242132 · Fabinject Lndustria E Comercio Lmportacao E Exportacao Ltda · Oct 2024